AI assistant
Natera, Inc. — Director's Dealing 2025
Nov 4, 2025
30253_dirs_2025-11-03_dd201d3e-e9b1-40d2-8638-87df651cfb95.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Natera, Inc. (NTRA)
CIK: 0001604821
Period of Report: 2025-11-03
Reporting Person: Chapman Steven Leonard (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-11-03 | Common Stock | M | 2084 | $13.01 | Acquired | 151924 | Direct |
| 2025-11-03 | Common Stock | M | 3595 | $20.27 | Acquired | 155519 | Direct |
| 2025-11-03 | Common Stock | M | 150000 | $119.75 | Acquired | 305519 | Direct |
| 2025-11-03 | Common Stock | S | 2215 | $198.0293 | Disposed | 303304 | Direct |
| 2025-11-03 | Common Stock | S | 1915 | $198.9619 | Disposed | 301389 | Direct |
| 2025-11-03 | Common Stock | S | 156573 | $199.9983 | Disposed | 144816 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-11-03 | Stock Option (right to buy) | $13.01 | M | 2084 | Disposed | 2029-01-10 | Common Stock (2084) | Direct |
| 2025-11-03 | Stock Option (right to buy) | $20.27 | M | 3595 | Disposed | 2029-04-11 | Common Stock (3595) | Direct |
| 2025-11-03 | Stock Option (right to buy) | $119.75 | M | 150000 | Disposed | 2031-01-21 | Common Stock (150000) | Direct |
Footnotes
F1: The sale of shares on this form was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023, as amended on December 2, 2024. The sale of 150,000 of these shares was governed by the initial plan and not altered by the subsequently amendment.
F2: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $197.28 to $198.27 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $198.44 to $199.43 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $199.51 to $200.00 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5: The option shares are fully exercisable.
F6: On January 22, 2021, the Reporting Person was granted performance-based options which vest in tranches upon the achievement of milestones relating to a combination of the passage of time and certain business performance criteria. The performance thresholds were certified on June 28, 2024, March 28, 2025 and September 28, 2025, resulting in the performance-based option being fully vested as of the last performance threshold date.